KORU Medical Systems Analyst Ratings
KORU Medical Systems Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/06/2023 | 21.62% | Piper Sandler | $3.5 → $4.5 | Maintains | Overweight |
| 11/10/2022 | 8.11% | Canaccord Genuity | $3 → $4 | Upgrades | Hold → Buy |
| 11/10/2022 | -5.41% | Piper Sandler | $3 → $3.5 | Upgrades | Neutral → Overweight |
| 01/26/2021 | 35.14% | Canaccord Genuity | → $5 | Downgrades | Buy → Hold |
| 01/26/2021 | 21.62% | Piper Sandler | $9 → $4.5 | Downgrades | Overweight → Neutral |
| 11/05/2020 | 170.27% | Canaccord Genuity | $13 → $10 | Maintains | Buy |
| 07/16/2020 | 251.35% | Canaccord Genuity | → $13 | Initiates Coverage On | → Buy |
| 06/24/2020 | 224.32% | Piper Sandler | → $12 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 01/06/2023 | 21.62% | 派珀·桑德勒 | $3.5→$4.5 | 維護 | 超重 |
| 2022年11月10日 | 8.11% | 卡納科特·格納奇 | $3→$4 | 升級 | 持有→購買 |
| 2022年11月10日 | -5.41% | 派珀·桑德勒 | $3→$3.5 | 升級 | 中性→超重 |
| 2021/01/26 | 35.14% | 卡納科特·格納奇 | →$5 | 評級下調 | 購買→Hold |
| 2021/01/26 | 21.62% | 派珀·桑德勒 | $9→$4.5 | 評級下調 | 超重→中性 |
| 11/05/2020 | 170.27% | 卡納科特·格納奇 | $13→$10 | 維護 | 買 |
| 07/16/2020 | 251.35% | 卡納科特·格納奇 | →$13 | 開始承保 | →購買 |
| 06/24/2020 | 224.32% | 派珀·桑德勒 | →$12 | 開始承保 | →超重 |
What is the target price for KORU Medical Systems (KRMD)?
Koru醫療系統(KRMD)的目標價格是多少？
The latest price target for KORU Medical Systems (NASDAQ: KRMD) was reported by Piper Sandler on January 6, 2023. The analyst firm set a price target for $4.50 expecting KRMD to rise to within 12 months (a possible 21.62% upside). 3 analyst firms have reported ratings in the last year.
派珀·桑德勒於2023年1月6日報道了科魯醫療系統公司(納斯達克代碼：KRMD)的最新目標價。這家分析公司將目標價定為4.50美元，預計韓元兌美元將在12個月內上漲至21.62%(可能上漲21.62%)。3家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for KORU Medical Systems (KRMD)?
科魯醫療系統公司(KRMD)的最新分析師評級是多少？
The latest analyst rating for KORU Medical Systems (NASDAQ: KRMD) was provided by Piper Sandler, and KORU Medical Systems maintained their overweight rating.
派珀·桑德勒提供了對科魯醫療系統公司(納斯達克代碼：KRMD)的最新分析師評級，科魯醫療系統公司維持其增持評級。
When is the next analyst rating going to be posted or updated for KORU Medical Systems (KRMD)?
Koru Medical Systems(KRMD)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of KORU Medical Systems, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for KORU Medical Systems was filed on January 6, 2023 so you should expect the next rating to be made available sometime around January 6, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Koru醫療系統的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Koru醫療系統的上一次評級是在2023年1月6日提交的，因此您應該預計下一次評級將在2024年1月6日左右提供。
Is the Analyst Rating KORU Medical Systems (KRMD) correct?
分析師對Koru醫療系統(KRMD)的評級正確嗎？
While ratings are subjective and will change, the latest KORU Medical Systems (KRMD) rating was a maintained with a price target of $3.50 to $4.50. The current price KORU Medical Systems (KRMD) is trading at is $3.70, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Koru Medical Systems(KRMD)評級保持不變，目標價在3.50美元至4.50美元之間。Koru醫療系統(KRMD)目前的交易價格為3.70美元，在分析師的預測範圍內。